产后出血患者血液管理专家共识(2022年版)

2022-01-30 中国输血协会临床输血学专业委员会中国临床新医学

产后出血(PPH)是产科的危重症,需要通过患者血液管理(PBM)改善预后。中国输血协会临床输血学专业委员会制订了PPH的PBM专家共识(2022年版)。该共识强调PBM一定要基于PPH正确处理的基础上

中文标题：

发布机构：

中国输血协会临床输血学专业委员会

发布日期：

2022-01-30

简要介绍：

产后出血(PPH)是产科的危重症,需要通过患者血液管理(PBM)改善预后。中国输血协会临床输血学专业委员会制订了PPH的PBM专家共识(2022年版)。该共识强调PBM一定要基于PPH正确处理的基础上。该共识重视血小板和凝血因子的功能和数量的管理,明确了多种情况下血小板和新鲜冰冻血浆等的输注指征。该共识还明确提出了实施大量输血程序的办法。

相关资料下载：

GetToolGuiderByIdResponse(projectId=1, id=95e9d1c002351665, title=产后出血患者血液管理专家共识(2022年版), enTitle=, guiderFrom=中国临床新医学, authorId=0, author=, summary=产后出血(PPH)是产科的危重症,需要通过患者血液管理(PBM)改善预后。中国输血协会临床输血学专业委员会制订了PPH的PBM专家共识(2022年版)。该共识强调PBM一定要基于PPH正确处理的基础上, cover=https://img.medsci.cn/2022211/1644591826390_5579292.png, journalId=0, articlesId=null, associationId=2396, associationName=中国输血协会临床输血学专业委员会, associationIntro=中国输血协会临床输血学专业委员会, copyright=0, guiderPublishedTime=Sun Jan 30 00:00:00 CST 2022, originalUrl=, linkOutUrl=, content=<p><span style="color: #333333;">产后出血(PPH)是产科的危重症,需要通过患者血液管理(PBM)改善预后。中国输血协会临床输血学专业委员会制订了PPH的PBM专家共识(2022年版)。该共识强调PBM一定要基于PPH正确处理的基础上。该共识重视血小板和凝血因子的功能和数量的管理,明确了多种情况下血小板和新鲜冰冻血浆等的输注指征。该共识还明确提出了实施大量输血程序的办法。 </span></p>, tagList=[TagDto(tagId=25227, tagName=产后出血), TagDto(tagId=114249, tagName=患者血液管理), TagDto(tagId=119394, tagName=产科疾病)], categoryList=[CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5992, appHits=175, showAppHits=0, pcHits=1354, showPcHits=5816, likes=1, shares=36, comments=7, approvalStatus=1, publishedTime=Sat Feb 12 15:00:00 CST 2022, publishedTimeString=2022-01-30, pcVisible=1, appVisible=1, editorId=0, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=FUNNYMAN, createdTime=Fri Feb 11 23:06:34 CST 2022, updatedBy=5579292, updatedName=FUNNYMAN, updatedTime=Sat Jan 06 19:34:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=产后出血患者血液管理专家共识(2022年版).pdf)])

产后出血患者血液管理专家共识(2022年版).pdf

下载请点击：

评论区 (6)

#插入话题

插入图片

[GetPortalCommentsPageByObjectIdResponse(id=2111892, encodeId=06aa2111892c6, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=488b2518136, createdName=124d3556m04暂无昵称, createdTime=Sat Jan 28 20:31:31 CST 2023, time=2023-01-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1204410, encodeId=d477120441042, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:42:10 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194699, encodeId=a0ec11946994f, content=日新月异啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Fri Feb 18 08:31:33 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194500, encodeId=9bfa119450080, content=随时更新，紧跟相关研究进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76445177887, createdName=146ee1d2m67暂无昵称, createdTime=Thu Feb 17 16:47:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193107, encodeId=c06e119310e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:35:48 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
2023-01-28 124d3556m04暂无昵称来自北京

好棒

76 0
[GetPortalCommentsPageByObjectIdResponse(id=2111892, encodeId=06aa2111892c6, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=488b2518136, createdName=124d3556m04暂无昵称, createdTime=Sat Jan 28 20:31:31 CST 2023, time=2023-01-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1204410, encodeId=d477120441042, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:42:10 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194699, encodeId=a0ec11946994f, content=日新月异啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Fri Feb 18 08:31:33 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194500, encodeId=9bfa119450080, content=随时更新，紧跟相关研究进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76445177887, createdName=146ee1d2m67暂无昵称, createdTime=Thu Feb 17 16:47:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193107, encodeId=c06e119310e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:35:48 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
2022-03-20 120c570cm03暂无昵称

学习

96 0
[GetPortalCommentsPageByObjectIdResponse(id=2111892, encodeId=06aa2111892c6, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=488b2518136, createdName=124d3556m04暂无昵称, createdTime=Sat Jan 28 20:31:31 CST 2023, time=2023-01-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1204410, encodeId=d477120441042, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:42:10 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194699, encodeId=a0ec11946994f, content=日新月异啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Fri Feb 18 08:31:33 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194500, encodeId=9bfa119450080, content=随时更新，紧跟相关研究进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76445177887, createdName=146ee1d2m67暂无昵称, createdTime=Thu Feb 17 16:47:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193107, encodeId=c06e119310e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:35:48 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
2022-02-18 泡泡糖111

日新月异啊

105 0
[GetPortalCommentsPageByObjectIdResponse(id=2111892, encodeId=06aa2111892c6, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=488b2518136, createdName=124d3556m04暂无昵称, createdTime=Sat Jan 28 20:31:31 CST 2023, time=2023-01-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1204410, encodeId=d477120441042, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:42:10 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194699, encodeId=a0ec11946994f, content=日新月异啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Fri Feb 18 08:31:33 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194500, encodeId=9bfa119450080, content=随时更新，紧跟相关研究进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76445177887, createdName=146ee1d2m67暂无昵称, createdTime=Thu Feb 17 16:47:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193107, encodeId=c06e119310e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:35:48 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
2022-02-17 146ee1d2m67暂无昵称

随时更新，紧跟相关研究进展

124 0
[GetPortalCommentsPageByObjectIdResponse(id=2111892, encodeId=06aa2111892c6, content=好棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=488b2518136, createdName=124d3556m04暂无昵称, createdTime=Sat Jan 28 20:31:31 CST 2023, time=2023-01-28, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1204410, encodeId=d477120441042, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=96, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b4ab2205971, createdName=120c570cm03暂无昵称, createdTime=Sun Mar 20 19:42:10 CST 2022, time=2022-03-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194699, encodeId=a0ec11946994f, content=日新月异啊 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a3845482238, createdName=泡泡糖111, createdTime=Fri Feb 18 08:31:33 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194500, encodeId=9bfa119450080, content=随时更新，紧跟相关研究进展, beContent=null, objectType=guider, channel=null, level=null, likeNumber=124, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=76445177887, createdName=146ee1d2m67暂无昵称, createdTime=Thu Feb 17 16:47:34 CST 2022, time=2022-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1193107, encodeId=c06e119310e1e, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89ae6481716, createdName=ms3000000637975859, createdTime=Sun Feb 13 21:35:48 CST 2022, time=2022-02-13, status=1, ipAttribution=)]
2022-02-13 ms3000000637975859

学习了

119 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

妇产科指南

产后出血患者血液管理专家共识(2022年版)

相关指南

科室

工具

服务